Psychedelics Optimi Health submits clinical trial application after developing proprietary MDMA drug The drug will be used to help establish a safe supply for patients in Canada and Australia Rowan DunneFebruary 7, 2023
Canada Optimi makes history with gargantuan psilocybin harvest Company believes it has completed the largest mushroom harvest Canada has ever seen Rowan DunneSeptember 9, 2022
Research Psychedelic use rising as the market expands: MicroSmallCap New report outlines statistics and recent accomplishments made in the field Rowan DunneSeptember 6, 2022
Canada Optimi receives amendment from Health Canada permitting MDMA production Vancouver producer to supply synthetic psychedelic compounds to designated investigators and companies Rowan DunneAugust 16, 2022
Business Optimi enters natural psilocybin supply agreement with Filament Health The mushrooms will be grown and distributed from Optimi's 20,000 square foot EU-GMP facility in Princeton Natalia Buendia CalvilloMay 31, 2022